Robert Jeffrey Kaner, M.D.

Pulmonary Disease Medicine

Publications

Stover DE and Kaner RJ. Pulmonary Toxicity in DeVita VT, Hellman S and Rosenberg SA eds): Cancer Principles and Practice of Oncology, 7th Edition, J.P. Lippincott. 2535-2545, 2005.

Kaner RJ. Pulmonary Complications of Allogeneic Bone Marrow Transplantation.Pulmonary Up-To-Date Series on CD, 1996-2005..

Kaner RJ, Worgall S, Leoold PL, Stolze E, Milano E, Hidaka C, Ramalingam R, Hackett NR, Singh R, Bergelson J, Finberg R, Falck-Pedersen E, and Crystal RG. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie /adenovirus receptor. Am J Respir Cell Mol Biol, 1999; Mar 1;20(3):361-370.

Kaner RJ, Ladetto J, Singh R, Fukuda N, Matthay M and Crystal RG. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol 22:657-664, 2000.

Kaner RJ and Crystal RG. Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung. Molecular Medicine, April 2001; 7(4):240-246.

Kaner RJ, Crystal RG. Pathogenesis of high altitude pulmonary edema: does alveolar epithelial lining fluid vascular endothelial growth factor exacerbate capillary leak? High Alt Med Biol. 2004;5(4):399-409.

Back to topBack To Top